No products in the cart.
Rabbit Anti-EIF2B1 Antibody (CSB-PA623910ESR2HU)
Supplier: CUSABIO BIOTECH CO.
Translation initiation factor eIF-2B subunit alpha Antibody,eIF-2B GDP-GTP exchange factor subunit alpha Antibody,EIF2B1 Antibody,EIF2BA AntibodyMore alternative names for the antibody
EI2BA_HUMAN antibody|eIF-2B GDP-GTP exchange factor subunit alpha antibody|EIF2B antibody|Eif2b1 antibody|EIF2BA antibody|Eukaryotic translation initiation factor 2B subunit 1 alpha 26kDa antibody|Translation initiation factor eIF-2B subunit alpha antibody
Anti-EIF2B1 antibody (ab170662)
Anti-EIF2B1 antibody (ab170662)
Recommended applications: ELISA, WB, IHC
Recommended dilution: User optimized
Recommended protocols: check protocols
|Catalogue No.|| |
Recombinant human Translation initiation factor eIF-2B subunit alpha protein (1-305AA)
ELISA, WB, IHC
|Recommended dilution|| |
|Molecular weight|| |
Antigen Affinity Purified
Shipped at 4 Celcius Degree. Upon delivery aliquot and store at -20 Celcius Degree or -80 Celcius Degree. Avoid repeated freeze.
|Database links|| |
<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=1967" target="_blank">Entrez Gene:1967( Human)</a>, <a href="http://www.ncbi.nlm.nih.gov/omim/606686" target="_blank">Omim:606686( Human)</a>, <a href="http://www.uniprot.org/uniprot/Q14232" target="_blank">SwissProt:Q14232( Human)</a>, <a href="http://www.ncbi.nlm.nih.gov/UniGene/clust.cgi?ORG=Hs&CID=741273" target="_blank">Unigene:741273( Human)</a>
|Protein function|| |
Catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP.
|Involvement in disease|| |
Leukodystrophy with vanishing white matter (VWM) [MIM:603896]: A leukodystrophy that occurs mainly in children. Neurological signs include progressive cerebellar ataxia, spasticity, inconstant optic atrophy and relatively preserved mental abilities. The disease is chronic-progressive with, in most individuals, additional episodes of rapid deterioration following febrile infections or minor head trauma. While childhood onset is the most common form of the disorder, some severe forms are apparent at birth. A severe, early-onset form seen among the Cree and Chippewayan populations of Quebec and Manitoba is called Cree leukoencephalopathy. Milder forms may not become evident until adolescence or adulthood. Some females with milder forms of the disease who survive to adolescence exhibit ovarian dysfunction. This variant of the disorder is called ovarioleukodystrophy. . Note=The disease is caused by mutations affecting the gene represented in this entry.
|Protein sequence and domain|| |
Belongs to the eIF-2B alpha/beta/delta subunits family.
|Research area|| |
<a href="https://antibodyplus.com/research-areas/">All research areas</a>><a href="https://antibodyplus.com/Signaling-Intermediates/">Signaling Intermediates</a>><a href="https://antibodyplus.com/product-tag/eIF/">eIF</a><br><a href="https://antibodyplus.com/product-tag/Signaling-Intermediates/"> (View all antibody categories related to Signaling Intermediates)</a>
AntibodyPlus provides antibody trial sample for your own antibody validation and collects antibody reviews.
CUSABIO BIOTECH CO.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: